Form D · Biotechnology

Globavir Biosciences Inc.

Los Altos, CA · CIK 0001632042

Offering snapshot reported Nov 10, 2015 · SEC filing

Reported sold
$150K
Offering amount: $10M
Investors reported
1
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Sep 25, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$75K$150KOct 6, 2015: $100,000.00Oct 6, 2015Nov 10, 2015: $150,000.00Nov 10, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$100,000 → $150,000
  • Minimum accepted$50,000 → $49,998

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 10, 2015Amendment$150,000$50,000vs Oct 6, 20151SEC filing
Oct 6, 2015Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-248799

Source: Form D, filed Nov 10, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gilad Gordon Executive
Shalabh Gupta Director, Executive
George Jue Executive
Sandeep Laumas Director
John Ryan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5150 El Camino Real Suite #A 32
Los Altos, CA, 94022